Reich, K., Lebwohl, M., Paul, C., Ropke, M., Rosen, M., & Hansen, K. (2018). Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis. SKIN The Journal of Cutaneous Medicine, 2(S1), S1. https://doi.org/10.25251/skin.2.supp.1